The John Marshall Law School

The Intersection of IP
and Public Health

Friday, November 8, 2013
9 a.m. – 5 p.m.

Register Now

CLE Credit: 5.75 Hours (Approximately)
Cost: $50 (Free for JMLS faculty and students)

What role should IP play in affordable health care? Some experts support stronger protections for IP rights to spur and reward innovation. Others urge relaxing protections to promote access and facilitate progress. This is not only a domestic U.S. issue – the balance of rights and access must be addressed on a global scale, especially in light of recent developments such as the Indian Supreme Court’s denial of protection for the Novartis cancer drug Glivec.

Industry leaders and academic experts will address:

  • Orphan drug development, its role within larger health care spending, and its regulatory role in the future of generic pharmaceuticals
  • The state of personalized medicine and genetic patents after Myriad
  • The Novartis Indian Supreme Court decision and the implications for branded pharmaceutical protection
  • The role of regulation in increasing competition as a substitute for pharmaceutical patents
  • IP rights and access in West Africa, Jordan, Turkey, India, and other emerging economies
  • The consequences of the upcoming loss of patent protection for many prominent drugs and a growth in generic pharmaceuticals
  • Lessons from other health care and intellectual property rights models


8 – 9:15 a.m.

Registration & Welcome

9:15 – 9:45 a.m.

A Scientific Approach to IP: Innovation, Access, and
a Forgotten Corner of the Universal Declaration
of Human Rights

Adam Houston
Vancouver Island Human Rights Coalition

9:45 – 10:15 a.m.

Regulatory Competitive Shelters in the Regulation of Biomedical Technologies

Yaniv Heled
Assistant Professor
Georgia State University College of Law

10:30 – 11 a.m.

Patenting Identities: The Other Side of Myriad

Shubha Ghosh
University of Wisconsin Law School

11 – 11:45 a.m.

Drugged Out: How Cognitive Bias Hurts Drug Innovation

Cynthia Ho
Clifford E. Vickrey Research Professor
Director, Intellectual Property Program
Loyola University School of Law

12:15 – 1:15 p.m.

Keynote Address

Kevin Noonan
McDonnell Boehnen Hulbert & Berghoff LLP
(Founding author of the Patent Docs Weblog)

1:15 – 1:45 p.m.

Social Justice Meets Property Law: Realigning Patent Law’s Asymmetric Contour in Novartis v. Union of India & Others

Saby Ghoshray, PhD
President, Interdisciplinary Studies
Vice President, Development and Compliance

WorldCompliance Company

1:45 – 2:15 p.m.

Pinwheel of Fortune

James Chen
Justin Smith Morrill Chair in Law
Michigan State University College of Law

2:30 – 3 p.m.

Adopting Pharmacogenomics and Parenting Repurposed Molecules under the Orphan Drug Act: A Cost Dilemma

David C. Babaian
University of Washington

3 – 3:30 p.m.

Patenting Drugs in Canada: Differences and Dividing Lines North and South of the Border

Nancy Pei
Smart & Biggar Fetherstonhaugh

3:30 – 4 p.m.

Analyzing Trade Agreements' Effects on Access to Medicine in Jordan

Bashar Malkawi
Associate Professor of Law
University of Sharjah, College of Law (United Arab Emirates)

4– 4:30 p.m.

Implementing and Enforcing Intellectual Property Rights in West Africa

Ganiyou Gassikia

4:30 – 5:30 p.m.